Ezetimibe Tablet
Product Images NDC 16714-813

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 16714-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (10 mg (30 Tablets Bottle))

Package Label.principal Display Panel (10 mg (30 Tablets Bottle))
NDG 16714-813-01 is a pack of Ezetimibe Tablets, containing 30 tablets with each tablet having 10mg of ezstimibe USP. These tablets are manufactured for Norhstar x LLG, Memphis, TN 38141 and manufactured by Aurobindo Pharma Limited from India. These tablets are generally prescribed to be taken once daily and should be stored at 20° to 25°C (68° to 77°F) under controlled room temperature. The pack comes with additional instructions and the product is protected from moisture. The M.LNo. of the product is 22MNAPI2009FR and it was issued in 11/2020.*
FDA Label Image

Structure (Ezetimibe Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.